Irene C. Huffnagel - Concepedia

Author

Irene C. Huffnagel

Emma Kinderziekenhuis ORCID

Also Known As

Huffnagel, Irene, I.C. Huffnagel, Irene C Huffnagel, Irene C. Huffnagel, Irene Huffnagel

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Emma Kinderziekenhuis Amsterdam UMC Location University of Amsterdam University of Amsterdam Amsterdam University Medical Centers OLVG

About

Irene C. Huffnagel is an author at Emma Kinderziekenhuis specializing in medicine, clinical trials, and adrenal disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	168
2	Neurology	2	2	130
3	Pharmacology	2	2	108
4	Health Sciences	1	1	60
5	Rehabilitation	1	1	60

Irene C. Huffnagel

Publications

687

Citations

H-Index

Page 1

	Year	Citations
The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration Irene C. Huffnagel, Fiza Laheji, Razina Aziz‐Bose, The Journal of Clinical Endocrinology & Metabolism	2018	146
International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy Marc Engelen, Wouter J. C. van Ballegoij, Eric J. Mallack, Neurology	2022	128
Disease progression in women with X-linked adrenoleukodystrophy is slow Irene C. Huffnagel, Marcel G. W. Dijkgraaf, Georges E. Janssens, Orphanet Journal of Rare Diseases	2019	91
Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy Irene C. Huffnagel, Malu-Clair van de Beek, Amanda Showers, Molecular Genetics and Metabolism Adrenal GlandDried Blood SpotsMedicinePhysiologyNeurology	2017	70
Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness Irene C. Huffnagel, Wouter J. C. van Ballegoij, Björn M. van Geel, Brain Clinical DisordersAdrenal GlandUrologyHealth SciencesDisease Progression	2018	60
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial Wolfgang Köhler, Marc Engelen, Florian Eichler, The Lancet Neurology Non-pharmacological InterventionDisease ProgressionDiabetic NeuropathyPharmacologyClinical Trials	2023	38
Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy Wouter J. C. van Ballegoij, Stephanie I. W. van de Stadt, Irene C. Huffnagel, Annals of Clinical and Translational Neurology	2020	33
Mitochondrial Encephalopathy and Transient 3-Methylglutaconic Aciduria in ECHS1 Deficiency: Long-Term Follow-Up Irene C. Huffnagel, E. Redeker, Liesbeth Reneman, JIMD Reports	2017	28
Rhizomelic chondrodysplasia punctata and cardiac pathology Irene C. Huffnagel, Sally‐Ann B. Clur, Annemieke M. Bams-Mengerink, Journal of Medical Genetics	2013	26
Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy Yorrick Jaspers, Hemmo A. F. Yska, Caroline G. Bergner, Communications Medicine	2024	25

Page 1